Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Drug Targeting TLRs in Cutaneous Lupus Looks Good in Mid-Stage Studies

Drug Targeting TLRs in Cutaneous Lupus Looks Good in Mid-Stage Studies
ShareXFacebook

(MedPage Today) -- Enpatoran, an investigational oral drug that inhibits Toll-like receptors (TLR) 7 and 8, was superior to placebo in relieving lupus skin manifestations in a dose-finding phase II trial. Doses of 25, 50, and 100 mg twice daily...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

When a Patient Portal Alone Won't Suffice
MedPage Today

When a Patient Portal Alone Won't Suffice

(MedPage Today) -- Over the weekend, when my wife and I were heading home from a late afternoon movie followed by a stop to pick up some ice cream, we remembered that we needed to stop by the pharmacy. Since we moved into the neighborhood 30 years...

Read more →
Advertisement